Prof Timothy IllidgeBSc PhD FRCP FRCR FRCPath

Professor of Targeted Therapy & Oncology

Full contact details
View graph of relations

Publications

  1. 2019
  2. Published

    Evaluation of apoptosis imaging biomarkers in a genetic model of cell death

    Vassileva, V., Stribbling, S. M., Barnes, C., Carroll, L., Braga, M., Abrahams, J., Heinzmann, K., Haegeman, C., MacFarlane, M., Simpson, K. L., Dive, C., Honeychurch, J., Illidge, T. M. & Aboagye, E. O., 2019, In : EJNMMI Research. 9, 18.

    Research output: Contribution to journalArticle

  3. Published

    The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper

    British Society for Haematology Guidelines, 2019, In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  4. 2018
  5. Published

    British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018

    Gilson, D., Whittaker, S. J., Child, F. J., Scarisbrick, J. J., Illidge, T. M., Parry, E. J., Mohd Mustapa, M. F., Exton, L. S., Kanfer, E., Rezvani, K., Dearden, C. E. & Morris, S. L., 17 Dec 2018, In : The British journal of dermatology.

    Research output: Contribution to journalArticle

  6. E-pub ahead of print

    Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    ECHELON-2 Study Group, 3 Dec 2018, In : Lancet (London, England).

    Research output: Contribution to journalArticle

  7. E-pub ahead of print

    Clinical Development of Novel Drug-Radiotherapy Combinations

    Ahmad, S. S., Crittenden, M. R., Tran, P. T., Kluetz, P. G., Blumenthal, G. M., Bulbeck, H., Baird, R. D., Williams, K. J., Illidge, T., Hahn, S. M., Lawrence, T. S., Spears, P. A., Walker, A. J. & Sharma, R. A., 29 Nov 2018, In : Clinical cancer research : an official journal of the American Association for Cancer Research.

    Research output: Contribution to journalArticle

  8. Published

    Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    ESMO Guidelines Committee, 1 Oct 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, Supplement_4, p. iv19-iv29

    Research output: Contribution to journalArticle

  9. Published

    Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas

    Fanale, M. A., Horwitz, S. M., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Illidge, T., Uttarwar, M., Lee, S-Y., Ren, H., Kennedy, D. A. & Shustov, A. R., 10 May 2018, In : Blood. 131, 19, p. 2120-2124

    Research output: Contribution to journalArticle

  10. Published

    The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group

    Constine, L. S., Yahalom, J., Ng, A. K., Hodgson, D. C., Wirth, A., Milgrom, S. A., Mikhaeel, N. G., Eich, H. T., Illidge, T., Ricardi, U., Dieckmann, K., Moskowitz, C. H., Advani, R., Mauch, P. M., Specht, L. & Hoppe, R. T., 1 Apr 2018, In : International Journal of Radiation Oncology Biology Physics. 100, 5, p. 1100-1118

    Research output: Contribution to journalReview article

  11. Published

    Recommendations for the clinical management of the elderly patient with malignant lymphoma

    Specht, L., Aleman, B., Eich, H., Illidge, T. M., Kirova, Y., Mikhaeel, N. G., Ricardi, U. & Yahalom, J., Apr 2018, In : Annals of Oncology. 29, 4, p. 1069-1070

    Research output: Contribution to journalLetter

  12. Published

    The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer

    Walshaw, R. C., Honeychurch, J., Illidge, T. M. & Choudhury, A., Apr 2018, In : Nature Reviews Urology. 15, 4, p. 251-259

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...15 Next